Merck KGaA (MKKGY)
32.90
+1.51
(+4.81%)
USD |
OTCM |
Apr 23, 16:00
Merck Shareholders Equity (Quarterly): 29.49B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 29.49B |
September 30, 2023 | 29.87B |
June 30, 2023 | 29.02B |
March 31, 2023 | 28.51B |
December 31, 2022 | 27.80B |
September 30, 2022 | 27.78B |
June 30, 2022 | 27.11B |
March 31, 2022 | 25.58B |
December 31, 2021 | 24.16B |
September 30, 2021 | 23.90B |
June 30, 2021 | 22.96B |
March 31, 2021 | 22.18B |
December 31, 2020 | 20.84B |
September 30, 2020 | 21.05B |
June 30, 2020 | 20.22B |
March 31, 2020 | 20.47B |
December 31, 2019 | 19.98B |
September 30, 2019 | 19.87B |
June 30, 2019 | 19.95B |
March 31, 2019 | 19.81B |
December 31, 2018 | 19.68B |
September 30, 2018 | 17.76B |
June 30, 2018 | 17.15B |
March 31, 2018 | 17.32B |
December 31, 2017 | 16.80B |
Date | Value |
---|---|
September 30, 2017 | 16.18B |
June 30, 2017 | 15.68B |
March 31, 2017 | 15.41B |
December 31, 2016 | 14.79B |
September 30, 2016 | 14.49B |
June 30, 2016 | 14.22B |
March 31, 2016 | 14.17B |
December 31, 2015 | 13.98B |
September 30, 2015 | 15.70B |
June 30, 2015 | 15.52B |
March 31, 2015 | 14.89B |
December 31, 2014 | 14.28B |
September 30, 2014 | 14.88B |
June 30, 2014 | 15.23B |
March 31, 2014 | 15.39B |
December 31, 2013 | 15.22B |
September 30, 2013 | 14.48B |
June 30, 2013 | 13.67B |
March 31, 2013 | 13.40B |
December 31, 2012 | 13.70B |
September 30, 2012 | 13.57B |
June 30, 2012 | 13.04B |
March 31, 2012 | 14.10B |
December 31, 2011 | 13.53B |
September 30, 2011 | 14.11B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.87B
Minimum
Sep 2019
29.87B
Maximum
Sep 2023
24.25B
Average
23.90B
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Affimed NV | 63.90M |
InflaRx NV | 113.39M |
MorphoSys AG | 54.22M |
BioNTech SE | 22.38B |
Immatics NV | 248.81M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 53.61B |
Total Liabilities (Quarterly) | 24.03B |
Debt to Equity Ratio | 0.3504 |
Current Ratio | 1.425 |
Net Debt Paydown Yield | 0.15% |